Kyungho Paul Park, MS.

Research Scientist - Kyungho Park, MS., has special interests in gene therapy, immunotherapy, and tumor  biology. His previous research focused on the development and optimization of gene therapy delivery systems, including viral and non-viral vectors to treat genetic disorders and cancer. He has worked extensively on CAR T-cell therapy, gene editing (e.g., CRISPR-Cas9), and pre-clinical studies of tumor biology, particularly in the context of PTEN-related tumors such as glioblastoma and neuroblastoma. His ultimate goal is to improve the safety and efficacy of gene therapy and immunotherapy strategies for cancer treatment. Kyungho Park was an active participant in several professional societies related to gene therapy , oncology, and immunology. He contributed to the scientific community through his research and involvement in academic and clinical collaborations.

In his free time, he plays tennis and bowling. He also enjoys watching science fiction movies and reading novels.